US Patent Issued to The Population Council, The United States of America, as rep'd by the Secy., Dept. of Health and Human Services on Dec. 23 for "Progestin/testosterone transdermal gel" (American, French Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,395, issued on Dec. 23, was assigned to The Population Council Inc. (New York) and The United States of America, as rep'd by the Secy., Dept. of Health and Human Services (Bethesda, Md.).

"Progestin/testosterone transdermal gel" was invented by Diana L. Blithe (Silver Spring, Md.), Min S. Lee (San Diego) and Regine Sitruk-Ware (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a specific combination of a progestin and testosterone in a transdermal composition and usage thereof in a method for ensuring male contraception with more efficacy and less side effects."

The patent was filed on Nov. 8, 2024, under Applic...